Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von James Harrison und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. Hauptthemen laut MEDLINE: Interleukin-18, Atherosclerosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, NHLBI NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Aims
The adaptive immune response plays an important role in atherosclerosis. In response to a high-fat/high-cholesterol (HF/HC) diet, marginal zone B (MZB) cells activate an atheroprotective programme by regulating the differentiation and accumulation of ‘poorly differentiated’ T follicular helper (Tfh) cells. On the other hand, Tfh cells activate the germinal centre response, which promotes atherosclerosis through the production of class-switched high-affinity antibodies. We therefore investigated the direct role of Tfh cells and the role of IL18 in Tfh differentiation in atherosclerosis. Methods and results We generated atherosclerotic mouse models with selective genetic deletion of Tfh cells, MZB cells, or IL18 signalling in Tfh cells. Surprisingly, mice lacking Tfh cells had increased atherosclerosis. Lack of Tfh not only reduced class-switched IgG antibodies against oxidation-specific epitopes (OSEs) but also reduced atheroprotective natural IgM-type anti-phosphorylcholine (PC) antibodies, despite no alteration of natural B1 cells. Moreover, the absence of Tfh cells was associated with an accumulation of MZB cells with substantially reduced ability to secrete antibodies. In the same manner, MZB cell deficiency in Ldlr−/− mice was associated with a significant decrease in atheroprotective IgM antibodies, including natural anti-PC IgM antibodies. In humans, we found a positive correlation between circulating MZB-like cells and anti-OSE IgM antibodies. Finally, we identified an important role for IL18 signalling in HF/HC diet–induced Tfh.
Conclusion
Our findings reveal a previously unsuspected role of MZB cells in regulating atheroprotective ‘natural’ IgM antibody production in a Tfh-dependent manner, which could have important pathophysiological and therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
- Laboratory for Vascular Translational Sciences (LVTS), Université de Paris, INSERM U1148, Paris, France.
- Department of Medicine, Brigham and Woman's Hospital, Harvard Medical School, Boston, MA, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
- Wellcome-MRC Institute of Metabolic Science and Medical Research Council Metabolic Diseases Unit, University of Cambridge, UK.
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Hema Kothari, Guo-Ping Shi, Jason M Tarkin, Ziad Mallat, Meritxell Nus
Förderung
- British Heart Foundation
- NHLBI NIH HHS
- Wellcome Trust
- Intermediate Basic Science Fellowship
- BHF Project Grants
- BHF Chair of Cardiovascular Medicine
- Leducq Foundation
- H2020
Zitieren
APA
Harrison, J., Newland, S. A., Jiang, W., Giakomidi, D., Zhao, X., Clement, M., Masters, L., Corovic, A., Zhang, X., Drago, F., Ma, M., Ozsvar Kozma, M., Yasin, F., Saady, Y., Kothari, H., Zhao, T. X., Shi, G. P., McNamara, C. A., Binder, C. J., …, & Nus, M. (2024). Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae027
Vancouver
Harrison J, Newland SA, Jiang W, Giakomidi D, Zhao X, Clement M, et al. Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae027
BibTeX
@article{Harrison2024,
author = {Harrison, James and Newland, Stephen A and Jiang, Wei and Giakomidi, Despoina and Zhao, Xiaohui and Clement, Marc and Masters, Leanne and Corovic, Andrej and Zhang, Xian and Drago, Fabrizio and Ma, Marcella and Ozsvar Kozma, Maria and Yasin, Froher and Saady, Yuta and Kothari, Hema and Zhao, Tian X and Shi, Guo-Ping and McNamara, Coleen A and Binder, Christoph J and Sage, Andrew P and Tarkin, Jason M and Mallat, Ziad and Nus, Meritxell},
title = {Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae027}
}
EUVIMED